Background: Endoscopic mucosal resection of large non-pedunculated colorectal polyps is characterized by a high risk of recurrence. Thermal ablation of the mucosal defect margins may reduce recurrence in these lesions, but a systematic overview of the current evidence is lacking.
Materials and methods: We searched Pubmed, Embase and Cochrance until July 2021, for studies on thermal ablation of mucosal defect margins of large non-pedunculated colorectal polyps. Main goal of this meta-analysis was to identify pooled risk difference of recurrence between thermal ablation vs. no adjuvant treatment. Secondary goal was to identify pooled recurrence rate after STSC and APC.
Results: Ten studies on thermal ablation of mucosal defect margins were included, with 3 studies on argon plasma coagulation, 6 studies on snare tip soft coagulation and 1 study comparing both treatment modalities, representing a total of 316 APC cases and 1598 STSC cases. Overall pooled risk difference of recurrence was -0.17 (95% CI -0.22 – -0.12) as compared to no adjuvant treatment. Pooled risk difference was -0.16 (95% CI -0.19 – -0.14) for STSC and -0.26 (95% CI -0.80 – 0.28) for APC. Pooled recurrence rate was 4% (95%-CI 2-8%) for STSC and 9% (95%-CI 4-19%) for APC.
Conclusions: Thermal ablation of mucosal defect margins significantly reduces recurrence rate in large non-pedunculated colorectal lesions compared to no adjuvant treatment. While no evidence for superiority exists, snare tip soft coagulation may be preferred over argon plasma coagulation, because this method is the most evidence-based, and cost-effective modality.